Search

Danaher Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

215.05 -1.73

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

212.98

Max

218.74

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-159M

870M

Pardavimai

314M

6.3B

P/E

Sektoriaus vid.

36.119

57.371

Pelnas, tenkantis vienai akcijai

1.94

Dividendų pajamingumas

0.71

Pelno marža

13.887

Darbuotojai

58,000

EBITDA

353M

1.8B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+0.42% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.71%

2.23%

Kitas uždarbis

2026-10-20

Kitas dividendų mokėjimo data

2026-10-30

Kita Ex Dividend data

2026-09-25

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

106M

142B

Ankstesnė atidarymo kaina

216.78

Ankstesnė uždarymo kaina

215.05

Naujienos nuotaikos

By Acuity

22%

78%

48 / 340 reitingas Healthcare

Danaher Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-21 20:06; UTC

Danaher Corp. shares are higher during Friday's session, reflecting overall gains since Thursday's close amid a strong market backdrop, including rising Bitcoin prices.

2026-08-20 22:06; UTC

Correlated Moves

Danaher Corp shares are higher in after-market hours, supported by positive movement in the life sciences sector following Repligen Corp's recent increase.

2026-08-19 20:02; UTC

News

Danaher Corp shares reached a 24-week high, reflecting strong market sentiment. The stock is up significantly since Tuesday's close, supported by positive investor sentiment.

2026-08-18 23:31; UTC

Danaher Corp shares advanced in after-market trading, recovering from earlier dips and positioning near the upper end of their one-month range.

2026-08-17 19:16; UTC

Danaher Corp shares are lower amid broader market concerns over slowing economic growth and disappointing U.S. retail sales data. No specific company news was identified.

2026-08-14 20:06; UTC

Danaher Corp's shares are lower amid concerns over a surprising drop in U.S. retail sales, which fell 0.6% in July against expectations.

2026-08-13 23:31; UTC

Danaher Corp shares rose in after-market trading, buoyed by unchanged producer prices in July and easing inflation concerns affecting investor sentiment.

2026-08-12 23:46; UTC

Danaher Corp. shares were roughly flat in after-market trading, maintaining a position above its 20-day moving average and near the upper end of its one-month range.

2026-08-10 19:42; UTC

Danaher Corp shares are higher today, supported by a broader rise in the Life Sciences Tools & Services sub-sector. The stock remains above its 20-day moving average.

2026-08-07 19:36; UTC

News

Danaher Corp's stock is higher today, supported by significant insider transactions. The CFO and Executive Vice President reported acquiring substantial stock options.

2026-08-06 20:02; UTC

Shares of Danaher Corp are higher, reflecting broader market gains since Wednesday's close. The stock is near the upper end of its one-month range.

2026-08-05 19:51; UTC

Danaher Corp shares are higher today, supported by gains in the Life Sciences Tools & Services sub-sector. The stock has shown notable volatility during the session.

2026-08-04 23:01; UTC

Danaher Corp shares are higher in after-market trading, supported by broader market optimism and easing oil prices contributing to favorable inflation expectations.

2026-08-03 22:51; UTC

News

Danaher Corp appointed Julie Sawyer Montgomery as President and CEO, effective October 1, 2026. Shares are trading higher in after-market hours.

2026-07-31 23:01; UTC

Danaher Corp shares are lower in after-market trading, with no specific news identified to explain the decline amid broader market weakness.

2026-07-30 18:01; UTC

Danaher Corp. shares are lower today, fluctuating within their one-month range amid volatility influenced by the Federal Reserve's interest rate decisions.

2026-07-29 23:01; UTC

Danaher Corp shares are higher in after-market trading, reflecting a slight increase since Wednesday's close. The stock reached a recent high shortly after 5:10 PM ET.

2026-07-28 23:01; UTC

Danaher Corp shares declined in after-hours trading amid broader market losses linked to concerns over artificial intelligence spending and competition from Chinese chipmakers.

2026-07-27 23:16; UTC

Danaher Corp shares are lower in after-market trading, declining slightly since Monday's close. No specific company news has been identified to explain the movement.

2026-07-24 20:06; UTC

News

Danaher Corp shares are lower amid concerns over reduced sales growth in its biotechnology segment, despite raising full-year earnings guidance to $8.45-$8.60.

2026-07-23 10:01; UTC

Danaher Corp shares are lower in pre-market trading, continuing a decline since Wednesday's close and remaining below the 20-day moving average.

2026-07-22 22:01; UTC

Danaher Corp shares are trading lower in after-market hours, continuing a trend of six consecutive sessions finishing lower amid rising crude oil prices and market volatility.

2026-07-21 19:41; UTC

News
Social Media

Danaher Corp shares are lower after the company issued a cautious fiscal 2026 revenue growth forecast despite reporting better-than-expected second-quarter earnings and revenues.

2026-07-20 23:41; UTC

Danaher Corp shares declined in after-market trading, continuing a trend of lower finishes amid concerns over economic momentum and a drop in the leading economic index.

Akcijų palyginimas

Kainos pokytis

Danaher Corp Prognozė

Kainos tikslas

By TipRanks

0.42% į viršų

12 mėnesių prognozė

Vidutinis 219.78 USD  0.42%

Aukščiausias 240 USD

Žemiausias 195 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Danaher Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

20 ratings

17

Pirkti

3

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

48 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
help-icon Live chat